1st Quarter - Report

VIATRIS INC. for VIATRIS INC

Firm
Client
Income
—
Expenses
$670,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

6 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Drug pricing issues, access to generic medicines, Medicare Part D program and generic drugs Generic drug quality and FDA oversight Part D Formulary Design and Generic Drug Tiering Electronic Labeling of Prescription Drugs FDA facility inspections Medicare incentives for biosimilar utilization Generic Drug User Fee Amendments (GDUFA) Complex Generic Drug Approvals H.R. 3 - Lower Drug Costs Now Act H.R. 2846 - Ensuring Access to Lower-Cost Medicines for Seniors Act Biosimilar interchangeability H.R. 5376 - Build Back Better Act H.R. 6973, Enhanced Access to Affordable Medicines Act of 2022 H.R. 7032, Increasing Transparency in Generic Drug Applications Act of 2022

LobbyistCovered position, as disclosed
WILL DENT New Legislative Correspondent and Legislative Assistant for Senator Johnny Isakson
KATHARINE HAYES —
DAVID MARIN —
PETER WALLACE —
ANNE WILSON —

Contacted: Office of Management & Budget (OMB); SENATE; HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); Food & Drug Administration (FDA); Centers For Disease Control & Prevention (CDC); Health & Human Services, Dept of (HHS)

Bills named: H.R. 7032 (117th), H.R. 3 (117th), H.R. 6973 (117th), H.R. 5376 (117th), H.R. 2846 (117th)

Budget/Appropriations BUD

Medicaid Rebate provision of the Bipartisan Budget Act of 2015

LobbyistCovered position, as disclosed
WILL DENT New Legislative Correspondent and Legislative Assistant for Senator Johnny Isakson
KATHARINE HAYES —
DAVID MARIN —
PETER WALLACE —
ANNE WILSON —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Copyright/Patent/Trademark CPT

Issues related Inter Partes Review (IPR) process for biosimilars and generic drugs Patent Settlements

LobbyistCovered position, as disclosed
WILL DENT New Legislative Correspondent and Legislative Assistant for Senator Johnny Isakson
KATHARINE HAYES —
DAVID MARIN —
PETER WALLACE —
ANNE WILSON —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Trade (domestic/foreign) TRD

Trade issues related to generic medicines Pharmaceutical supply chain

LobbyistCovered position, as disclosed
WILL DENT New Legislative Correspondent and Legislative Assistant for Senator Johnny Isakson
KATHARINE HAYES —
DAVID MARIN —
PETER WALLACE —

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Commerce, Dept of (DOC)

Financial Institutions/Investments/Securities FIN

Policy related to corporate governance

LobbyistCovered position, as disclosed
DAVID MARIN —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Taxation/Internal Revenue Code TAX

Corporate Tax Policy

LobbyistCovered position, as disclosed
KATHARINE HAYES —
DAVID MARIN —
PETER WALLACE —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.